Modular Medical, INC 10-Q quarterly reports

Modular Medical, Inc. filed its Form 10-Q for the quarter ended June 30, 2026, detailing continued operating losses and substantial doubt regarding its ability to continue as a going concern.

Modular Medical, a pre-revenue medical device company, reported increased operating losses and a significant cash burn, raising substantial doubt about its ability to continue as a going concern.

Modular Medical, Inc. reported increased operating losses and a significant cash burn, raising substantial doubt about its ability to continue as a going concern, while also facing Nasdaq delisting due to its stock price.

Modular Medical, Inc. announces its Q3 2025 results, emphasizing FDA clearance for its MODD1 insulin pump and ongoing efforts towards commercialization despite a going concern warning.

Modular Medical has filed an amendment to its quarterly report to correct an error regarding the electronic submission of interactive data files.

Modular Medical, a pre-revenue medical device company, announced its second quarter 2025 results, highlighting FDA clearance for its MODD1 insulin pump while reporting continued operating losses.

Modular Medical reported its Q1 2025 financial results, highlighting ongoing losses and raising concerns about the company's ability to continue as a going concern.

Modular Medical's Q3 report shows increased research and development expenses as the company prepares for FDA clearance of its MODD1 insulin pump.